查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448559

全球临床试验影像市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Clinical Trial Imaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 286 Pages | 商品交期: 最快1-2个工作天内

价格

全球临床试验影像市场需求预计将从2023年的21.9亿美元达到2032年近44.1亿美元的市场规模，2024-2032年研究期间CAGR为8.09%。

临床试验影像涉及使用各种影像技术（例如 MRI、CT 和 PET）来评估和分析临床试验中的医疗状况或治疗结果。这些影像为研究人员和临床医生提供了有价值的资料，有助于评估治疗效果、疾病进展和患者反应。

市场动态

临床试验影像市场的驱动因素包括临床试验日益复杂、医学影像技术的进步以及药物开发中对客观定量成像资料的需求。随着製药和生物技术公司寻求透过整合成像端点来提高临床试验的效率和准确性，该市场正在经历成长。影像技术可以对疾病进展和治疗反应进行非侵入性监测，促进早期决策并减少侵入性手术的需要。此外，监管机构越来越多地接受医学影像作为临床试验中有价值的生物标誌物，这也有助于市场的扩张。精准医学的兴起和标靶治疗的发展进一步推动了对影像技术的需求，以识别合适的患者族群。该市场也受到分散和虚拟临床试验采用的影响，其中成像在远端监控和资料收集中至关重要，反映了临床试验方法不断发展的模式。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球临床试验影像市场的每个细分市场进行包容性评估。临床试验成像产业的成长和趋势为这项研究提供了整体方法。

市场区隔

临床试验影像市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按服务

  • 临床试验设计与咨询服务
  • 阅读与分析服务
  • 营运影像服务
  • 系统和技术支援服务
  • 专案和资料管理

按方式

  • CT检查
  • 磁振造影
  • X射线
  • 超音波
  • 光学相干断层扫描 (OCT)
  • 其他的

按应用

  • 非酒精性脂肪性肝炎
  • 慢性肾臟病
  • 糖尿病
  • 心血管疾病
  • 眼科
  • 肌肉骨骼
  • 肿瘤学
  • 胃肠病学
  • 儿科
  • 其他的

按最终用途

  • 生物技术和製药公司
  • 医疗器材製造商
  • 学术和政府研究机构
  • 合约研究组织 (CRO)
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲临床试验成像市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。临床试验成像市场的主要参与者包括 IXICO plc、Navitas Life Sciences、Resonance Health、ProScan Imaging、Radiant Sage LLC、Medpace、Biomedical Systems Corp、心血管成像技术、Intrinsic Imaging、BioTelemetry。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：临床试验影像 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按服务分類的市场吸引力分析
    • 按形式分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球临床试验影像市场分析：按服务分类

  • 按服务概览
  • 历史和预测数据
  • 按服务分析
  • 临床试验设计与咨询服务
  • 阅读与分析服务
  • 营运影像服务
  • 系统和技术支援服务
  • 专案和资料管理

第 6 章：全球临床试验影像市场分析：按模式

  • 依方式概述
  • 历史和预测数据
  • 按形态分析
  • CT检查
  • 磁振造影
  • X射线
  • 超音波
  • 光学相干断层扫描 (OCT)
  • 其他的

第 7 章：全球临床试验影像市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 非酒精性脂肪性肝炎
  • 慢性肾臟病
  • 糖尿病
  • 心血管疾病
  • 眼科
  • 肌肉骨骼
  • 肿瘤学
  • 胃肠病学
  • 儿科
  • 其他的

第 8 章：全球临床试验影像市场分析：依最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 生物技术和製药公司
  • 医疗器材製造商
  • 学术和政府研究机构
  • 合约研究组织 (CRO)
  • 其他的

第 9 章：全球临床试验影像市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：临床试验影像公司的竞争格局

  • 临床试验影像市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • IXICO plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Navitas Life Sciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Resonance Health
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ProScan Imaging
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Radiant Sage LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medpace
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biomedical Systems Corp
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cardiovascular Imaging Technologies
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Intrinsic Imaging
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BioTelemetry
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113786

The global demand for Clinical Trial Imaging Market is presumed to reach the market size of nearly USD 4.41 Billion by 2032 from USD 2.19 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

Clinical trial imaging involves the use of various imaging techniques, such as MRI, CTs, and PET, to assess and analyze medical conditions or treatment outcomes in clinical trials. These images provide valuable data for researchers and clinicians, aiding in the evaluation of treatment efficacy, disease progression, and patient response.

MARKET DYNAMICS

The clinical trial imaging market is driven by the increasing complexity of clinical trials, advancements in medical imaging technologies, and the demand for objective and quantitative imaging data in drug development. The market experiences growth as pharmaceutical and biotechnology companies seek to enhance the efficiency and accuracy of clinical trials by incorporating imaging endpoints. Imaging technologies allow for non-invasive monitoring of disease progression and treatment response, facilitating early decision-making and reducing the need for invasive procedures. Additionally, regulatory agencies' increasing acceptance of medical imaging as a valuable biomarker in clinical trials contributes to the market's expansion. The rise in precision medicine and the development of targeted therapies further drive the demand for imaging techniques to identify suitable patient populations. The market is also influenced by the adoption of decentralized and virtual clinical trials, where imaging is crucial in remote monitoring and data collection, reflecting the evolving landscape of clinical trial methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial imaging. The growth and trends of clinical trial imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Clinical Trial Design And Consultation Services
  • Reading And Analytical Services
  • Operational Imaging Services
  • System And Technology Support Services
  • Project And Data Management

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography (OCT)
  • Others

By Application

  • NASH
  • CKD
  • Diabetes
  • Cardiovascular Diseases
  • Ophthalmology
  • Musculoskeletal
  • Oncology
  • Gastroenterology
  • Pediatrics
  • Others

By End Use

  • Biotechnology And Pharmaceutical Companies
  • Medical Devices Manufacturers
  • Academic And Government Research Institutes
  • Contract Research Organizations (CROs)
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Imaging market include IXICO plc, Navitas Life Sciences, Resonance Health, ProScan Imaging, Radiant Sage LLC, Medpace, Biomedical Systems Corp, Cardiovascular Imaging Technologies, Intrinsic Imaging, BioTelemetry. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL TRIAL IMAGING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Modality
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY SERVICE

  • 5.1 Overview by Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service
  • 5.4 Clinical Trial Design And Consultation Services Historic and Forecast Sales by Regions
  • 5.5 Reading And Analytical Services Historic and Forecast Sales by Regions
  • 5.6 Operational Imaging Services Historic and Forecast Sales by Regions
  • 5.7 System And Technology Support Services Historic and Forecast Sales by Regions
  • 5.8 Project And Data Management Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY MODALITY

  • 6.1 Overview by Modality
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Modality
  • 6.4 Computed Tomography Historic and Forecast Sales by Regions
  • 6.5 Magnetic Resonance Imaging Historic and Forecast Sales by Regions
  • 6.6 X-Ray Historic and Forecast Sales by Regions
  • 6.7 Ultrasound Historic and Forecast Sales by Regions
  • 6.8 Optical Coherence Tomography (OCT) Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 NASH Historic and Forecast Sales by Regions
  • 7.5 CKD Historic and Forecast Sales by Regions
  • 7.6 Diabetes Historic and Forecast Sales by Regions
  • 7.7 Cardiovascular Diseases Historic and Forecast Sales by Regions
  • 7.8 Ophthalmology Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Historic and Forecast Sales by Regions
  • 7.10. Oncology Historic and Forecast Sales by Regions
  • 7.11 Gastroenterology Historic and Forecast Sales by Regions
  • 7.12 Pediatrics Historic and Forecast Sales by Regions
  • 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY END USE

  • 8.1 Overview by End Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End Use
  • 8.4 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.5 Medical Devices Manufacturers Historic and Forecast Sales by Regions
  • 8.6 Academic And Government Research Institutes Historic and Forecast Sales by Regions
  • 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions
  • 8.8 Others Historic and Forecast Sales by Regions

9 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL IMAGING COMPANIES

  • 10.1. Clinical Trial Imaging Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CLINICAL TRIAL IMAGING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. IXICO plc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Navitas Life Sciences
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Resonance Health
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ProScan Imaging
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Radiant Sage LLC
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Medpace
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Biomedical Systems Corp
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Cardiovascular Imaging Technologies
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Intrinsic Imaging
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. BioTelemetry
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Analysis Market by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Clinical Trial Imaging Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Imaging Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Imaging Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Modality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Global Market Analysis by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.